The effect of low and high dose empagliflozin on HbA1c and lipid profile in type 2 diabetes mellitus: A real-world data
OBJECTIVE: This study aims to evaluate the efficacy and safety of the addition of 10 or 25 mg of empagliflozin to patients with type 2 diabetes mellitus using a maximum tolerable dose of metformin and gliclazide. METHODS: A total of 60 patients who had been receiving a maximum tolerable dose of metf...
Main Authors: | Serhat Özçelik, Mehmet Çelik, Aşkı Vural, Bünyamin Aydın |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2020-03-01
|
Series: | İstanbul Kuzey Klinikleri |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=nci&un=NCI-22697 |
Similar Items
-
Correlation of glycosylated haemoglobin (HbA1c) levels with subclinical atherosclerosis in patients with type 2 diabetes mellitus
by: Fateh Al-Khaqani, et al.
Published: (2018-12-01) -
"SERUM FERRITIN IN TYPE 2 DIABETES MELLITUS AND ITS RELATIONSHIP WITH HbA1c"
by: F. Sharifi Sh. Sazandeh
Published: (2004-06-01) -
"SERUM FERRITIN IN TYPE 2 DIABETES MELLITUS AND ITS RELATIONSHIP WITH HbA1c"
by: F. Sharifi Sh. Sazandeh
Published: (2004-04-01) -
HbA1C and diabetes – an overview
by: S Pathmanathan, et al.
Published: (2014-01-01) -
HbA1c Test’s Accuracy as a Predictor for Diabetes with Complications Diagnosis: Further Analysis of the HbA1c Diabetes Mellitus Test
by: Cleary, Liam
Published: (2020)